Literature DB >> 20881403

Leukoaraiosis predicts poor outcome after spontaneous supratentorial intracerebral hemorrhage.

Yu Sam Won1, Pil-Wook Chung, Yong Bum Kim, Heui-Soo Moon, Bum-Chun Suh, Yong Taek Lee, Kwang-Yeol Park.   

Abstract

BACKGROUND AND AIMS: Leukoaraiosis (LA) is associated with aging and vascular risk factors, and is a risk factor of intracerebral hemorrhage (ICH) after treatment with warfarin or thrombolytic treatment for ischemic stroke. In this study, we sought to examine whether LA is a predictor of outcome after spontaneous ICH.
METHODS: We retrospectively analyzed 238 consecutive patients with spontaneous supratentorial ICH identified by a database search. Patients were divided into two groups according to neurological outcome at 90 days: patients with good outcomes (Glasgow Outcome Scale ≥4) and patients with poor outcomes. Demographic features, ICH characteristics, and LA severity as assessed by van Swieten score on brain CT were compared between the two groups.
RESULTS: Overall, 105 (44.1%) of the patients analyzed had poor outcomes. In univariate analysis, LA severity, ICH volume on initial brain CT, initial Glasgow Coma Scale (GCS), presence of intraventricular hemorrhage (IVH), old age, surgical treatment, and higher admission serum glucose level were associated with poor outcome. Multiple logistic regression analysis showed that severity of LA, initial GCS score, hematoma volume, presence of IVH, and surgical treatment were independent predictors of poor outcome.
CONCLUSION: LA is an independent predictor of poor neurological outcome in patients with spontaneous supratentorial ICH.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20881403     DOI: 10.1159/000320972

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  6 in total

Review 1.  [Difficult decisions in stroke therapy].

Authors:  M Endres; M Grond; W Hacke; M Ebinger; P D Schellinger; M Dichgans
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

2.  Impact of Cerebral Small Vessel Disease on Functional Recovery After Intracerebral Hemorrhage.

Authors:  Simone M Uniken Venema; Sandro Marini; Umme K Lena; Andrea Morotti; Michael Jessel; Charles J Moomaw; Christina Kourkoulis; Fernando D Testai; Steven J Kittner; H Bart Brouwers; Michael L James; Daniel Woo; Christopher D Anderson; Jonathan Rosand
Journal:  Stroke       Date:  2019-08-26       Impact factor: 7.914

Review 3.  Resumption of Anticoagulation After Intracranial Hemorrhage.

Authors:  Ivan Rocha Ferreira da Silva; Jennifer A Frontera
Journal:  Curr Treat Options Neurol       Date:  2017-09-30       Impact factor: 3.598

4.  Aggressive blood pressure reduction is not associated with decreased perfusion in leukoaraiosis regions in acute intracerebral hemorrhage patients.

Authors:  Mahesh Kate; Laura Gioia; Thomas Jeerakathil; Michael D Hill; Bronwen Gould; Rebecca McCourt; Dar Dowlatshahi; Shelagh Coutts; Jayme Kosior; Andrew Demchuk; Brian Buck; Kenneth Butcher
Journal:  PLoS One       Date:  2019-03-11       Impact factor: 3.240

5.  White Matter Hyperintensities and Functional Outcomes in Patients With Cerebral Hemorrhage: A Systematic Review and Meta-Analysis.

Authors:  Qian You; Yi Yang; Hongtao Hu
Journal:  Front Neurol       Date:  2022-03-21       Impact factor: 4.003

6.  Do Imaging Markers of Cerebral Small Vessel Disease Predict Hematoma Volume and Outcome in Acute Intracerebral Hemorrhage?

Authors:  Anand R Warrier; Rohit Bhatia; Ajay Garg; M V Padma Srivastava; Deepa Dash; Manjari Tripathi; Mamta Bhushan Singh; Vishwajeet Singh; Sreenivas Vishnubhatla; Kameshwar Prasad
Journal:  Ann Indian Acad Neurol       Date:  2020-07-24       Impact factor: 1.383

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.